Azcuris

Pharmaceutical Manufacturing • Room 34−402, College of Pharmacy, Korea, Republic of • 1-10 Employees

Company overview

Headquarters	Room 34−402, College of Pharmacy, KU Sejong, 2511 Sejong−ro, Sejong 30019, South Korea, Sejong, - None - 30019, KR
Website	azcuris.com
NAICS	3254
Keywords	Copd, R&D, Allergies, Asthma, Cytokines, Atopic Dermatitis, Structure Based Drug Discovery
Founded	2018
Employees	1-10

Key Contacts at Azcuris

Ho Soon Kim

Chief Technology Officer

Young Jeon

Chief Executive Officer

Sang-Hyun Son

Director

About Azcuris

Azcuris aims to discover and develop innovative therapeutic solutions that can address medical unmet needs for patients with immune disease. Oral medicines that are highly effective and easy to take are our top priorities. Targeting cytokines in the pathogenesis of immune diseases, we are pioneering a new field of small-molecule drugs.

Azcuris revenue & valuation

Annual revenue	$855,550
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$2,800,000
Total funding	No funding

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Entry

C-Suite

Manager

Employees by Department

Azcuris has 4 employees across 3 departments.

Departments

Number of employees

Funding Data

Azcuris has never raised funding before.

Frequently asked questions

Azcuris is located in Room 34−402, College of Pharmacy, KR.

Azcuris was founded in 2018, making it 8 years old. The company has established itself as a significant player in its industry over this time.

Azcuris has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.